Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial

Len Rosenberg, Hugh Levaux, Ross L. Levine, Amit Shah, James Denmark, Nyla Hereema, Melanie Owen, Spencer Kalk, Nicholas Kenny, Gene Vinson, Jo Anne Vergilio, Alice Mims, Uma Borate, William Blum, Eytan Stein, Theophilus J. Gana, Mona Stefanos, Ashley Yocum, Sonja Marcus, Abigail ShobenBrian Druker, John Byrd, Amy Burd

Research output: Contribution to journalArticlepeer-review


Advances in genomic technologies and an increased understanding of the molecular pathogenesis of cancer have resulted in development of new effective, mutation-targeted therapies. In turn, these informed the development of Master Trial designs to test these therapies. The Beat Acute Myeloid Leukemia (BAML) Master Trial (Sponsor: The Leukemia & Lymphoma Society) tests several targeted therapies in patients aged ≥ 60 years with AML based on genomic profiling obtained within 7 days of study enrollment. We hypothesized that integrating operational strategies with new electronic technologies (e-technologies) might streamline the conduct and management of this Master Trial. BAML’s 5 core operational strategies revolve around the guiding principle of “patients first.” The e-technology platforms employed in BAML include: Clinical Oversight Platform: a central collaborative tool; e-Protocol/e-Source Upload/Electronic Data Capture Platform: digitizes the protocol, allows remote data monitoring, and collects/exports data in Study Data Tabulation Model format; and Data Review Platform: ingests data from different sources for clinical response and safety data reviews. The operational approaches, e-technologies and sponsor/contract research organization’s (CRO) expertise together allow: the complexity and size of the BAML Master Trial to be better managed; near real-time study data oversight; better collaboration, communication and training; improved data collection, enhanced transmission and accessibility; data integration, review and generation of reports; while maintaining data privacy, and compliance. Initial e-technology challenges were overcome through training, learning, discipline and adjustment. In conclusion, to successfully manage Master Trials, significant time should be spent re-evaluating, improving and developing new operational approaches. Clinical Trial Registration: Clinical Identifier: NCT03013998.

Original languageEnglish (US)
Pages (from-to)926-935
Number of pages10
JournalTherapeutic Innovation and Regulatory Science
Issue number5
StatePublished - Sep 2021
Externally publishedYes


  • Artificial intelligence
  • Clinical trials
  • E-technologies
  • EDC
  • EHR-to-EDC
  • Remote monitoring

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)


Dive into the research topics of 'Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial'. Together they form a unique fingerprint.

Cite this